Jason C Ye (@jasonyeradonc) 's Twitter Profile
Jason C Ye

@jasonyeradonc

Radiation Oncologist specializing in thoracic cancer, breast cancer, and brain and spine tumors at @keckmedusc ✌️| Book appointment at link below.

ID: 1064233641616625664

linkhttps://providers.keckmedicine.org/provider/Jason+Ye/250576 calendar_today18-11-2018 19:07:27

280 Tweet

432 Followers

376 Following

Jason C Ye (@jasonyeradonc) 's Twitter Profile Photo

Excellent talk on brain metastases by Dr. Minesh Mehta at #ASCO24 There are now some systemic therapies that work great in the CNS. Unfortunately they only work for a small proportion of cancers that spread to the brain. #RT especially #SRS is the standard therapy for most.

Excellent talk on brain metastases by Dr. Minesh Mehta at #ASCO24 
There are now some systemic therapies that work great in the CNS. Unfortunately they only work for a small proportion of cancers that spread to the brain. #RT especially #SRS is the standard therapy for most.
Joe Y Chang (@joechangmd) 's Twitter Profile Photo

Keep heart V40 <20% is crucial to minimize heart toxicities and improve survival for stage III NSCLC treated with concurrent chemoradiothetapy.

Jason C Ye (@jasonyeradonc) 's Twitter Profile Photo

It was a great fun day at the 13th annual GO2 for Lung Cancer SoCal walk/run to support research and treatment of #lungcancer! Keck Medicine of USC team had amazing turnout and fundraising. Fight on! ✌🏻

It was a great fun day at the 13th annual <a href="/GO2forLungCancr/">GO2 for Lung Cancer</a> SoCal walk/run to support research and treatment of #lungcancer! <a href="/KeckMedicineUSC/">Keck Medicine of USC</a> team had amazing turnout and fundraising. Fight on! ✌🏻
USC Brain Tumor Center (uscbtc) (@uscbtc) 's Twitter Profile Photo

Saturday morning our USC BTC team and their families participated in the American Brain Tumor Association BT5K in Los Angeles. It was a beautiful sunny day in Santa Monica. The USC Brain Tumor Center is a proud sponsor of the BT5K. The funds raised, support their mission of providing critical funding

USC Brain Tumor Center (uscbtc) (@uscbtc) 's Twitter Profile Photo

The Second Annual Southern California Brain Tumor Conference is 1 week away! To advance brain tumor research, treatment, and therapies, the USC Brain Tumor Center is hosting the 2nd Annual Southern California Brain Tumor Conference which will be held in person at the USC Health

The Second Annual Southern California Brain Tumor Conference is 1 week away!

To advance brain tumor research, treatment, and therapies, the USC Brain Tumor Center is hosting the 2nd Annual Southern California Brain Tumor Conference which will be held in person at the USC Health
USC Brain Tumor Center (uscbtc) (@uscbtc) 's Twitter Profile Photo

One of the foremost challenges in the battle against cancer lies in advancing and elevating research, using innovative technologies, clinical trials, and transformative treatments. Today, at the Second Annual Southern California Brain Tumor Conference, leading experts from

One of the foremost challenges in the battle against cancer lies in advancing and elevating research, using innovative technologies, clinical trials, and transformative treatments.

Today, at the Second Annual Southern California Brain Tumor Conference, leading experts from
Radiology of USC (@radiologyusc) 's Twitter Profile Photo

Crossing the half-year mark with another strong one! Joshua Schiff, Asst Prof of Rad Onc, USC_Radonc, shares exciting innovations in biology-guided radiotherapy, a tool with the potential to define the future of radiation oncology. #GrandRounds #Radiology #RadOnc

Crossing the half-year mark with another strong one! <a href="/JoshuaSchiffMD/">Joshua Schiff</a>, Asst Prof of Rad Onc, <a href="/RadoncUsc/">USC_Radonc</a>, shares exciting innovations in biology-guided radiotherapy, a tool with the potential to define the future of radiation oncology. 

#GrandRounds #Radiology #RadOnc
Jason C Ye (@jasonyeradonc) 's Twitter Profile Photo

Honored to be invited by Bodour Salhia, PhD to discuss advancements in #breastcancer therapy, looking forward to the event on Saturday 3/29/25! If you or your friends/family would like to join, please register here: thebenchwithbedsideinitiative.usc.edu/rediating-hope… Keck Medicine of USC USC Norris Comprehensive Cancer Center #radonc

Honored to be invited by <a href="/bsalhia/">Bodour Salhia, PhD</a> to discuss advancements in #breastcancer therapy, looking forward to the event on Saturday 3/29/25! If you or your friends/family would like to join, please register here: thebenchwithbedsideinitiative.usc.edu/rediating-hope…

<a href="/KeckMedicineUSC/">Keck Medicine of USC</a> <a href="/uscnorris/">USC Norris Comprehensive Cancer Center</a> #radonc
RefleXion Medical (@reflexionmed) 's Twitter Profile Photo

Congratulations to USC Norris Comprehensive Cancer Center on opening your new, state-of-the-art facility in Newport Beach! The RefleXion X1 looks great in its new home. We are thrilled to see SCINTIX biology-guided radiotherapy become available to more patients throughout Orange County! #cancercare

Joshua Schiff (@joshuaschiffmd) 's Twitter Profile Photo

Congratulations to Hirsch Matani and the Newport Beach Keck Medicine of USC Rad Onc team ☢️ for treating our first patient with biology-guided radiotherapy this past week! The start of an exciting new chapter in advanced radiotherapy delivery USC_Radonc Keck Medicine of USC USC Norris Comprehensive Cancer Center 👏🏻

USC Norris Comprehensive Cancer Center (@uscnorris) 's Twitter Profile Photo

Lung cancer in young people is fundamentally different than it is in general lung cancer patient population where the average age is over 70. USC Norris member and thoracic medical oncologist Dr. Jorge Nieva discusses and shares insights from his innovative distributed clinical

Jason C Ye (@jasonyeradonc) 's Twitter Profile Photo

Exciting practice changing study in head and neck cancer with addition of immunotherapy improving outcomes (finally!) NIVOPOSTOP study showing improved DFS with nivolumab added to post-op chemoradition for high risk (mostly ECE and/or +margin) #ASCO2025

Exciting practice changing study in head and neck cancer with addition of immunotherapy improving outcomes (finally!) NIVOPOSTOP study showing improved DFS with nivolumab added to post-op chemoradition for high risk (mostly ECE and/or +margin) #ASCO2025